Asia Green Biotechnology (XCNQ:ASIA) Cash-to-Debt : 0.01 (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Asia Green Biotechnology Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Asia Green Biotechnology's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.01.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Asia Green Biotechnology couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for Asia Green Biotechnology's Cash-to-Debt or its related term are showing as below:

XCNQ:ASIA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: No Debt Max: No Debt
Current: 0.01

During the past 5 years, Asia Green Biotechnology's highest Cash to Debt Ratio was No Debt. The lowest was 0.01. And the median was No Debt.

XCNQ:ASIA's Cash-to-Debt is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.95 vs XCNQ:ASIA: 0.01

Asia Green Biotechnology Cash-to-Debt Historical Data

The historical data trend for Asia Green Biotechnology's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Asia Green Biotechnology Cash-to-Debt Chart

Asia Green Biotechnology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

No Debt

0.45

0.05

Asia Green Biotechnology Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Cash-to-Debt	Get a 7-Day Free Trial															0.03	0.05	0.02	0.01	0.01

Competitive Comparison of Asia Green Biotechnology's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Asia Green Biotechnology's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asia Green Biotechnology's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Asia Green Biotechnology's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Asia Green Biotechnology's Cash-to-Debt falls into.

Asia Green Biotechnology Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Asia Green Biotechnology's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.012	/	(0.15	+	0.075)
	=	0.05

Asia Green Biotechnology's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	0.002	/	(0.15	+	0.1)
	=	0.01

Asia Green Biotechnology (XCNQ:ASIA) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Asia Green Biotechnology Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Asia Green Biotechnology's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Asia Green Biotechnology (XCNQ:ASIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asia Green Biotechnology Corp (XCNQ:ASIA) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

707 - 7th Avenue SW, Suite 1150, Calgary, AB, CAN, T2P 3H6

Website

https://www.asiagreenbiotechnology.com

Asia Green Biotechnology Corp is an early stage international agri-technology company focused on the development, evaluation, testing, application and, ultimately, supply to the market of proprietary organic hybridization technology and certain products derived from that technology. The core approach of the business is centred on the planting, growth and harvesting of new and valuable strains of hemp and related crops in commercial quantities. The company is developing varieties of hemp with superior growth and production characteristics in the various environments found in the licensed territories.

Asia Green Biotechnology (XCNQ:ASIA) Headlines

No Headlines